App-Quantinova.ai

High on Aspirin Platelet Reactivity in Children Undergoing the Fontan Procedure

Yaser Diab - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Recurrent In-stent Thrombosis: An Atypical Presentation of Malignancy

Deborah L Crabbe - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Novel Quantitative Assessment of Whole Blood Thrombogenicity in Patients Treated with Anticoagulants Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation

Koichi Kaikita - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

One Hundred Consecutive Patients with Perceval Sutureless Valve: A Good Alternative to Standard Avr and Tavr

Annalisa Moggi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Low Left Ventricular Ejection Fraction and ?-blocker Use Before Admission is Associated with In-hospital Cardiac Complications in Patients with Takotsubo Cardiomyopathy

Yuichi Saito - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Device Selection: Does Ventricular Size Matter in LVAD Recipients?

Simon Maltais - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Essential Role of Platelet Glycoprotein Ib? Dependent Thrombin-FXI Feedback Loop in Arterial Hypertension, Vascular Dysfunction and Inflammation

Sven Jackel - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Angiotensin II

Is There Any End in Sight to This Debate on the Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Coronary Stent Implantation?

Xavier Perez - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Heparin Bridging in Atrial Fibrillation Patients After Temporary Interruption of Warfarin: Evidence From Meta-analysis

Ramez Nairooz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Very Long-term Clinical Outcome After Sirolimus-eluting Stent Implantation

Hiroaki Matsuda - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Clinical Outcomes of Patients Treated with First Generation vs. Second Generation Drug-eluting Stents for Left Main Coronary Artery Disease: A Meta-analysis

Abel Casso Dominguez - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Efficacy and Safety of Transradial Multi-vessel Coronary Artery Disease Intervention as Compared with Single Vessel Disease Intervention

Seung Woon Rha - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Ten-year Clinical Outcomes After the First Sirolimus-eluting Stent Implantation: Impact of In-stent Restenosis Lesion

Kazushige Kadota - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Duration of Dual Antiplatelet Therapy After Various Drug Eluting Stent Implantation

Manabu Nagao - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

Association of Silent Brain Infarction with CHADS2 Score and Left Atrial Abnormalities in Patients with Nonvalvular Atrial Fibrillation

Kenichi Sugioka - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous Thromboembolism Complications In Patients With Intracerebral Hemorrhage

Fernando Testai - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Diabetes Potentiates Ischemia-reperfusion (I/R) Brain Injury: Role for Methylglyoxal, Glutathione, and Cerebral Microvascular Thrombosis

Wei Li - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Streptozotocin

Carotid Narrowing and Stroke in Childhood Cavernous Sinus Thrombosis

Aaron J Lindsay - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Nimodipine

Rates of Ischemic Stroke after Intracranial Hemorrhage in a Population-Based Sample of Patients with Atrial Fibrillation

Gino Gialdini - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Alpha-2-antiplasmin Inactivation Reduces Brain Injury, Hemorrhage and Death Following Ischemic Stroke

Aiilyan Houng - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Filters

7277 Abstracts